20-hydroxyecdysone

Small moleculeexperimental

20-Hydroxyecdysone is a naturally occurring ecdysteroid hormone, which is marketed as dietary supplements that can increase strength and muscle mass during resistance training, particularly bodybuilding. It was found, that 20-hydroxyecdysone did not affect body composition or training adaptations nor did they influence the anabolic/catabolic hormone status or general markers of catabolism in resistance-trained males. Because is known, that ecdysteroids have been shown to prevent various changes in mammalian tissues after female sex hormone deprivation. 20-Hydroxyecdysone also was investigated on these properties. It was found in rats, that 20-Hydroxyecdysone had a beneficial effect on reducing blood pressure and consequently preventing dilated cardiac hypertrophy. Some in vitro experiments showed, that 20-hydroxyecdysone had effects on lymphocytes and neutrophils, and may act as an immunomodulator. — NCATS

Clinical trial activity

4 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0

Earliest trial started May 24, 2018 (NCT03452488)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C
Mol. weight
480.6341 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04827537Phase 2/Phase 3 (Phase 3)Jan 1, 2021Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
NCT04472728Phase 2/Phase 3 (Phase 3)Jun 16, 2020Biophytis, Sorbonne University
NCT03906201N/AFeb 6, 2019University of Guadalajara
NCT03452488Phase 2May 24, 2018Biophytis
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BiophytisFor profit2222018
Research Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanAcademic/Hospital1112021
Sorbonne UniversityAcademic/Hospital1012020
University of GuadalajaraAcademic/Hospital1112019
4 organizations
Page 1 / 1